» Articles » PMID: 34804934

Visualization of MicroRNA-21 Dynamics in Neuroblastoma Using Magnetic Resonance Imaging Based on a MicroRNA-21-Responsive Reporter Gene

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Nov 22
PMID 34804934
Authors
Affiliations
Soon will be listed here.
Abstract

Background: MicroRNAs (miRs) have been shown to be closely associated with the occurrence and development of tumors and to have potential as diagnostic and therapeutic targets. The detection of miRs by noninvasive imaging technology is crucial for deeply understanding their biological functions. Our aim was to develop a novel miR-21-responsive gene reporter system for magnetic resonance imaging (MRI) visualization of the miR-21 dynamics in neuroblastoma.

Methods: The reporter gene ferritin heavy chain (FTH1) was modified by the addition of 3 copies of the sequence completely complementary to miR-21 (3xC_miR-21) to its 3'-untranslated region (3' UTR) and transduced into SK-N-SH cells to obtain SK-N-SH/FTH1-3xC_miR-21 cells. Then, the antagomiR-21 was delivered into cells by graphene oxide functionalized with polyethylene glycol and dendrimer. Before and after antagomiR-21 delivery, FTH1 expression, MRI contrast and intracellular iron uptake were assayed and .

Results: In the SK-N-SH/FTH1-3xC_miR-21 cells, FTH1 expression was in an "off" state due to the combination of intratumoral miR-21 with the 3' UTR of the reporter gene. AntagomiR-21 delivered into the cells bound to miR-21 and thereby released it from the 3' UTR of the reporter gene, thus "switching on" FTH1 expression in a dose-dependent manner. This phenomenon resulted in intracellular iron accumulation and allowed MRI detection and .

Conclusion: MRI based on the miR-21-responsive gene reporter may be a potential method for visualization of the endogenous miR-21 activity in neuroblastoma and its response to gene therapy.

References
1.
He X, Cai J, Li H, Liu B, Qin Y, Zhong Y . In Vivo magnetic resonance imaging of xenografted tumors using FTH1 reporter gene expression controlled by a tet-on switch. Oncotarget. 2016; 7(48):78591-78604. PMC: 5346662. DOI: 10.18632/oncotarget.12519. View

2.
Kim H, Chung J, Hwang D, Lee D, Kim S . In vivo imaging of miR-221 biogenesis in papillary thyroid carcinoma. Mol Imaging Biol. 2008; 11(2):71-8. DOI: 10.1007/s11307-008-0188-6. View

3.
Chen Y, Tsai Y, Fang Y, Tseng S . Micro-RNA-21 regulates the sensitivity to cisplatin in human neuroblastoma cells. J Pediatr Surg. 2012; 47(10):1797-805. DOI: 10.1016/j.jpedsurg.2012.05.013. View

4.
Liu X, Song W, Sun T, Zhang P, Wang J . Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles. Mol Pharm. 2010; 8(1):250-9. DOI: 10.1021/mp100315q. View

5.
Cohen B, Ziv K, Plaks V, Harmelin A, Neeman M . Ferritin nanoparticles as magnetic resonance reporter gene. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010; 1(2):181-8. DOI: 10.1002/wnan.11. View